<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>Zonulin &#8211; Ayurved Healing</title>
	<atom:link href="https://www.ayurvedhealing.com/tag/zonulin/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.ayurvedhealing.com</link>
	<description>Ancient Wisdom for Modern Wellness</description>
	<lastBuildDate>Wed, 24 Jun 2026 05:04:30 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>

<image>
	<url>https://img.ayurvedhealing.com/wp-content/uploads/2026/06/ayurvedhealing-lotus-favicon-150x150.png</url>
	<title>Zonulin &#8211; Ayurved Healing</title>
	<link>https://www.ayurvedhealing.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Gut Permeability Testing and Ayurvedic Grahani: Bridging Lab Markers with Classical Diagnosis</title>
		<link>https://www.ayurvedhealing.com/gut-permeability-testing-grahani-lab-markers-classical-diagnosis/</link>
					<comments>https://www.ayurvedhealing.com/gut-permeability-testing-grahani-lab-markers-classical-diagnosis/#comments</comments>
		
		<dc:creator><![CDATA[Dr. Meera Iyer]]></dc:creator>
		<pubDate>Sat, 29 Aug 2026 07:30:00 +0000</pubDate>
				<category><![CDATA[Research & Science]]></category>
		<category><![CDATA[Classical Diagnosis]]></category>
		<category><![CDATA[Grahani]]></category>
		<category><![CDATA[Gut Permeability]]></category>
		<category><![CDATA[Integrative Research]]></category>
		<category><![CDATA[Lab Testing]]></category>
		<category><![CDATA[leaky gut]]></category>
		<category><![CDATA[Zonulin]]></category>
		<guid isPermaLink="false">https://www.ayurvedhealing.com/?p=3552</guid>

					<description><![CDATA[Two Diagnostic Systems, One Digestive Barrier The Ayurvedic concept of grahani roga and the modern concept of increased intestinal permeability describe digestive dysfunction from different frameworks. In Charaka Samhita, grahani is discussed in Chikitsa Sthana, Chapter 15, as the seat of agni that holds undigested food and releases it after digestion. When agni becomes weak [&#8230;]]]></description>
										<content:encoded><![CDATA[<h2>Two Diagnostic Systems, One Digestive Barrier</h2>
<p>The Ayurvedic concept of <em>grahani roga</em> and the modern concept of increased intestinal permeability describe digestive dysfunction from different frameworks. In <em>Charaka Samhita</em>, <em>grahani</em> is discussed in <em>Chikitsa Sthana</em>, Chapter 15, as the seat of <em>agni</em> that holds undigested food and releases it after digestion. When <em>agni</em> becomes weak or disturbed, <em>grahani</em> releases food in an incompletely processed form associated with <em>ama</em>, irregular stool, weakness, abdominal discomfort, and impaired nourishment.</p>
<p>Modern gastroenterology describes the intestinal lining as a selective barrier. The small-intestinal epithelium absorbs nutrients while limiting the passage of larger molecules, microbial products, and inflammatory triggers. Tight junction proteins, including claudins, occludin, junctional adhesion molecules, and zonula occludens scaffold proteins, help regulate this paracellular barrier. When barrier selectivity is altered, permeability testing may help characterize one part of the clinical picture, but it does not by itself diagnose <em>grahani roga</em>.</p>
<p>This article reviews verified permeability-related tests, classical <em>grahani</em> assessment, and a practical way to compare both systems without treating them as identical diagnoses.</p>
<h2>Modern Gut Permeability and Barrier Tests</h2>
<p>Modern tests do not measure one single entity called “leaky gut.” They examine different layers of gut function: sugar-probe permeability, intestinal inflammation, epithelial cell injury, and microbial endotoxin exposure. Their results are most useful when interpreted together with symptoms, examination, diet, medication use, and standard gastroenterology evaluation.</p>
<table border="1" cellpadding="8" cellspacing="0" style="width:100%; border-collapse:collapse; margin:20px 0;">
<thead style="background-color:#f5f0e8;">
<tr>
<th style="text-align:left;">Test</th>
<th style="text-align:left;">What It Measures</th>
<th style="text-align:left;">Sample Type</th>
<th style="text-align:left;">Strengths</th>
<th style="text-align:left;">Limitations</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lactulose-Mannitol Ratio (LMR)</td>
<td>Urinary recovery ratio of two orally ingested sugars used to estimate small-intestinal permeability</td>
<td>Urine, commonly collected over a 5- or 6-hour protocol depending on the laboratory</td>
<td>Direct functional sugar-probe method; used in permeability studies involving celiac disease, Crohn’s disease, malnutrition, medication effects, and barrier research</td>
<td>Protocols and reference ranges vary; results can be affected by timing, collection accuracy, gastric emptying, intestinal transit, renal handling, and recent medications</td>
</tr>
<tr>
<td>Zonulin or Zonulin-Family Peptides</td>
<td>Proteins related to tight-junction regulation, depending on assay design</td>
<td>Serum or stool</td>
<td>Simple collection and widely marketed as a barrier marker</td>
<td>Commercial assays may detect non-zonulin proteins or zonulin-family peptides rather than true pre-haptoglobin 2; results should not be used alone</td>
</tr>
<tr>
<td>Fecal Calprotectin</td>
<td>Neutrophil-associated intestinal inflammation</td>
<td>Stool</td>
<td>Useful non-invasive marker for inflammatory bowel disease assessment and for distinguishing inflammatory from many functional presentations</td>
<td>It measures inflammation rather than permeability; values may rise with infection, inflammatory bowel disease activity, NSAID use, and other inflammatory states</td>
</tr>
<tr>
<td>Intestinal Fatty Acid Binding Protein (I-FABP)</td>
<td>Enterocyte injury or epithelial cell damage</td>
<td>Blood, serum, or plasma</td>
<td>Reflects injury to intestinal epithelial cells, especially in acute or stress-related settings</td>
<td>Less useful as a routine standalone test for chronic functional digestive symptoms; levels can change quickly with acute injury and recovery</td>
</tr>
<tr>
<td>Lipopolysaccharide (LPS) or LPS-Binding Protein (LBP)</td>
<td>Exposure to Gram-negative bacterial endotoxin or host response to endotoxin</td>
<td>Blood</td>
<td>Can help characterize microbial translocation and systemic inflammatory context</td>
<td>Not specific to intestinal permeability; values can be influenced by infection, liver function, metabolic status, sample handling, and assay method</td>
</tr>
</tbody>
</table>
<h2>The Lactulose-Mannitol Test in Detail</h2>
<p>The lactulose-mannitol ratio is one of the best-established functional sugar-probe approaches for assessing intestinal permeability. The person ingests a solution containing lactulose and mannitol, then urine is collected for a defined period. Mannitol is smaller and is absorbed more readily, while lactulose is larger and is recovered in lower amounts when the barrier is intact. A higher lactulose-to-mannitol recovery ratio suggests increased paracellular passage or altered small-intestinal barrier function.</p>
<p>The main practical limitation is standardization. Collection duration, sugar dose, laboratory method, diet before testing, medication exposure, intestinal transit, and renal handling can change results. For this reason, the result should be interpreted using that laboratory’s reference range rather than a universal cut-off.</p>
<h2>Zonulin and Its Assay Caveat</h2>
<p>Zonulin is associated with reversible regulation of intestinal tight junctions and has become a popular marker in gut-barrier testing. Gliadin exposure and bacterial triggers have been described in relation to zonulin release and intestinal barrier regulation. In practice, however, zonulin testing requires caution because commonly used commercial assays may detect haptoglobin, complement C3, properdin, or zonulin-family peptides rather than true pre-haptoglobin 2.</p>
<p>A zonulin result is therefore best treated as an adjunctive signal rather than a standalone diagnosis. When symptoms are significant, it should be interpreted alongside medical history, stool pattern, inflammatory markers, celiac evaluation when indicated, medication exposure, and standard gastroenterology assessment.</p>
<h2>Grahani Diagnosis: The Classical Approach</h2>
<p><em>Grahani roga</em> is a clinical Ayurvedic diagnosis centered on <em>agni</em>, <em>ama</em>, stool character, appetite, abdominal sensations, strength, and dosha predominance. <em>Charaka Samhita</em> describes weak <em>agni</em> as producing partial digestion and explains that a disturbed <em>grahani</em> releases incompletely digested material. This is a digestive-function model, not a molecular tight-junction model, but the two can be compared when the comparison remains clinically cautious.</p>
<h3>The Four Types of Grahani Roga</h3>
<p><em>Charaka Samhita</em> classifies <em>grahani roga</em> into four types according to dosha predominance. The following descriptions keep the classical symptom pattern primary and use modern tests only as supportive tools for differential assessment.</p>
<ul>
<li><strong>Vataja grahani:</strong> Marked by difficult digestion, abdominal distension during digestion, dryness of the mouth and throat, emaciation, weakness, cutting pain, altered taste, reduced mental strength, and stool that may be watery, dry, small, mixed with flatus, or mixed with undigested food. Modern work-up may focus on functional bowel patterns, malabsorption, celiac screening when appropriate, constipation-diarrhea cycling, and permeability testing only when barrier assessment is clinically relevant.</li>
<li><strong>Pittaja grahani:</strong> Marked by loose or watery stool with undigested food particles, yellowish or bluish-yellow coloration, foul or sour eructation, burning in the chest or throat region, anorexia, and thirst. Modern work-up may prioritize inflammatory or acid-peptic features, stool infection assessment when clinically indicated, fecal calprotectin, celiac testing, and other gastroenterology evaluation if diarrhea is persistent.</li>
<li><strong>Kaphaja grahani:</strong> Marked by slow or difficult digestion, nausea, vomiting, anorexia, coated mouth, sweet taste, cough, frequent spitting, heaviness in the chest or abdomen, foul sweet eructation, mucus-mixed stool, laziness, and weakness even without marked wasting. Modern work-up may consider mucus-associated bowel disorders, dietary intolerance, dysbiosis-related symptoms, and breath testing when small-intestinal bacterial overgrowth is suspected.</li>
<li><strong>Sannipataja grahani:</strong> Marked by combined features of vata, pitta, and kapha involvement. Because mixed and severe presentations can overlap with inflammatory, infectious, autoimmune, malabsorptive, endocrine, or structural disease, a complete medical evaluation is more important than relying on permeability markers alone.</li>
</ul>
<table border="1" cellpadding="8" cellspacing="0" style="width:100%; border-collapse:collapse; margin:20px 0;">
<thead style="background-color:#f5f0e8;">
<tr>
<th style="text-align:left;">Grahani Type</th>
<th style="text-align:left;">Classical Pattern</th>
<th style="text-align:left;">Modern Assessment Priority</th>
<th style="text-align:left;">Potential Supportive Tests</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vataja</td>
<td>Variable stool, gas, distension, dryness, weakness, wasting, difficult evacuation</td>
<td>Clarify functional bowel pattern, malabsorption, diet triggers, transit irregularity, and celiac risk</td>
<td>CBC, metabolic panel, celiac serology when indicated, stool tests when diarrhea persists, LMR if barrier assessment is needed</td>
</tr>
<tr>
<td>Pittaja</td>
<td>Loose yellowish stool, sour or foul eructation, burning, thirst, anorexia</td>
<td>Look for inflammatory diarrhea, infection, acid-peptic disease, bile-related diarrhea, or celiac disease</td>
<td>Fecal calprotectin, CRP, stool infection tests when indicated, celiac serology, endoscopic evaluation when red flags are present</td>
</tr>
<tr>
<td>Kaphaja</td>
<td>Heaviness, nausea, coated mouth, sweet taste, mucus-mixed stool, sluggish digestion</td>
<td>Clarify mucus-associated bowel symptoms, dietary intolerance, dysbiosis-like presentations, and delayed digestion</td>
<td>Breath testing when SIBO is suspected, stool evaluation when chronic diarrhea is present, calprotectin if inflammation needs exclusion</td>
</tr>
<tr>
<td>Sannipataja</td>
<td>Mixed severe features involving all three doshas</td>
<td>Exclude inflammatory bowel disease, celiac disease, infection, endocrine disease, malignancy, and other serious causes</td>
<td>Full medical work-up guided by physician; permeability markers only as adjuncts</td>
</tr>
</tbody>
</table>
<h2>Where the Two Systems Can Be Compared</h2>
<p>The useful overlap between <em>grahani</em> and intestinal permeability is not a one-to-one diagnostic equivalence. Ayurveda asks whether digestive fire is steady, whether food is being properly processed, whether stool retains <em>ama</em> features, and which dosha pattern dominates. Modern testing asks whether the intestinal barrier, inflammatory state, epithelial integrity, or microbial translocation markers are altered. Used together, they can provide a wider clinical picture: classical assessment describes the digestive pattern, while laboratory testing helps identify inflammation, mucosal injury, malabsorption, infection, or barrier dysfunction.</p>
<p>This comparison is strongest when used as an integrative assessment map. A person can have <em>grahani</em>-like symptoms with normal permeability tests, and a person can have abnormal permeability markers due to an identifiable biomedical disorder. Persistent or severe symptoms therefore require medical evaluation rather than interpretation through either system alone.</p>
<h2>Ayurvedic Measures Traditionally Used in Grahani</h2>
<p>Classical Ayurvedic management of <em>grahani roga</em> is individualized according to <em>agni</em>, <em>ama</em>, dosha predominance, strength, stool pattern, and associated symptoms. The recurring principles are <em>langhana</em> when <em>ama</em> is prominent, <em>pachana</em> and <em>deepana</em> to improve digestive processing, <em>grahi</em> measures when loose stool requires stabilization, and dosha-specific cleansing only when the patient and disease stage are suitable.</p>
<ul>
<li><strong>Takra:</strong> <em>Charaka Samhita</em> praises buttermilk in <em>grahani dosha</em> because it is described as <em>deepana</em>, <em>grahi</em>, and light to digest. It is not a generic recommendation for every patient; the form, preparation, spices, dose, and timing are selected by the practitioner according to dosha and digestive strength.</li>
<li><strong>Kutaja:</strong> The Ayurvedic Pharmacopoeia of India identifies <em>Kutaja</em> stem bark as the dried stem bark of <em>Holarrhena antidysenterica</em>. Its listed properties include <em>tikta</em> and <em>kashaya rasa</em>, <em>laghu</em> and <em>ruksha guna</em>, <em>shita virya</em>, <em>katu vipaka</em>, and actions including <em>dipana</em>, <em>sangrahi</em>, and <em>kaphapittashamaka</em>. API-listed therapeutic uses include <em>atisara</em> and <em>pravahika</em>, making it relevant to loose-stool patterns under qualified supervision.</li>
<li><strong>Diet after shodhana:</strong> In pitta-dominant <em>grahani</em>, <em>Charaka Samhita</em> describes physician-directed elimination when indicated, followed by food that is light, non-burning, bitter-associated, and supported by <em>deepana</em> and <em>grahi</em> measures. This is a supervised clinical sequence, not a home detox protocol.</li>
<li><strong>Deepana and pachana measures:</strong> Classical management repeatedly returns to correcting weak or disturbed <em>agni</em>. Spices, medicated ghee, powders, gruels, and fermented preparations appear in the chapter according to dosha, stool quality, and strength. These should be selected individually rather than copied from a generic list.</li>
<li><strong>Triphala and gut-supportive herbs:</strong> Triphala is widely discussed in Ayurveda and modern gut-microbiome literature, but it should not be treated as a specific substitute for <em>grahani</em> diagnosis. For a separate discussion, see <a href="/triphala-reshapes-gut-2025-2026-microbiome-research/">How Triphala Reshapes Your Gut</a>.</li>
</ul>
<h2>An Integrative Diagnostic Protocol</h2>
<p>A practical integrative protocol starts with conventional safety screening and then adds Ayurvedic pattern assessment. This prevents a chronic digestive complaint from being mislabeled as <em>grahani</em> or “leaky gut” before serious causes are excluded.</p>
<ol>
<li><strong>Screen for red flags first:</strong> Unexplained weight loss, blood in stool, persistent night symptoms, anemia, fever, recurrent vomiting, severe abdominal pain, family history of colorectal cancer or inflammatory bowel disease, and new symptoms after midlife require medical evaluation.</li>
<li><strong>Assess the classical pattern:</strong> Evaluate appetite, meal tolerance, stool form, stool frequency, undigested food, mucus, burning, thirst, distension, heaviness, strength, tongue findings, and dosha predominance. Identify whether the presentation is closer to vataja, pittaja, kaphaja, or sannipataja <em>grahani</em>.</li>
<li><strong>Use modern tests for specific questions:</strong> Use fecal calprotectin to assess inflammatory activity, celiac serology when symptoms or risk factors fit, stool testing when infection is possible, breath testing when SIBO is suspected, and LMR when a permeability question will change management.</li>
<li><strong>Interpret discordance carefully:</strong> A classical <em>grahani</em> pattern with normal inflammatory markers may still require diet, routine, and <em>agni</em>-focused care. Abnormal calprotectin, anemia, blood in stool, persistent diarrhea, or significant weight loss should shift priority toward gastroenterology evaluation.</li>
<li><strong>Retest only when useful:</strong> Laboratory retesting should be reserved for markers that guide clinical decisions, such as calprotectin in inflammatory bowel disease monitoring or repeat testing after a defined intervention when a physician considers it meaningful.</li>
</ol>
<h2>Limitations and Safety</h2>
<p><em>Grahani roga</em> and increased intestinal permeability are not interchangeable diagnoses. <em>Grahani</em> is a classical Ayurvedic digestive disorder centered on <em>agni</em>, <em>ama</em>, dosha, and stool pattern. Intestinal permeability is a measurable barrier function that can be altered in specific biomedical conditions. “Leaky gut syndrome” is a popular term and is not a formal standalone medical diagnosis in mainstream clinical practice.</p>
<p>Permeability markers can also be misleading when used outside a full clinical context. Zonulin assay specificity, variable LMR protocols, medication effects, infection, alcohol intake, renal function, and inflammatory disorders can all affect interpretation. Fecal calprotectin and I-FABP add useful information in selected cases, but neither is a complete digestive diagnosis.</p>
<p>For those interested in how anti-inflammatory herbs are discussed in relation to gut and systemic inflammation, <a href="/cox-2-inhibition-explained-how-turmeric-boswellia-and-ginger-fight-inflammation/">COX-2 Inhibition Explained</a> provides a separate herb-focused discussion.</p>
<div style="background-color:#fff3cd; border:1px solid #ffc107; padding:15px; margin:20px 0; border-radius:5px;"> <strong>Medical Disclaimer:</strong> This article is for educational purposes only and does not constitute medical advice. Chronic digestive symptoms, alternating diarrhea and constipation, unexplained weight loss, blood in stool, persistent abdominal pain, anemia, fever, recurrent vomiting, or nighttime diarrhea require evaluation by a qualified healthcare provider. Ayurvedic herbs, <em>panchakarma</em>, <em>virechana</em>, <em>vamana</em>, and gut permeability testing should be used only with guidance from a qualified Ayurvedic practitioner and/or licensed healthcare professional. Do not self-diagnose or self-treat <em>grahani roga</em> or suspected intestinal permeability problems. </div>
<h2>References</h2>
<ol>
<li><a href="https://www.carakasamhitaonline.com/index.php/Grahani_Chikitsa" rel="nofollow noopener noreferrer" target="_blank">Charaka Samhita — Grahani Chikitsa</a></li>
<li><a href="https://www.ayurveda.hu/api/API-Vol-1.pdf" rel="nofollow noopener noreferrer" target="_blank">Ayurvedic Pharmacopoeia of India</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4316216/" rel="nofollow noopener noreferrer" target="_blank">Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases (2015), PubMed Central</a></li>
<li><a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0099256" rel="nofollow noopener noreferrer" target="_blank">Journals (journals.plos.org)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6687120/" rel="nofollow noopener noreferrer" target="_blank">Measurement of intestinal permeability using lactulose and mannitol with conventional five hours and shortened two hours urine collection by two different methods: HPAE-PAD and LC-MSMS (2019), PubMed Central</a></li>
<li><a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0210728" rel="nofollow noopener noreferrer" target="_blank">Journals (journals.plos.org)</a></li>
<li><a href="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2018.00022/full" rel="nofollow noopener noreferrer" target="_blank">Frontiersin (frontiersin.org)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6370282/" rel="nofollow noopener noreferrer" target="_blank">Faecal Calprotectin (2018), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6678629/" rel="nofollow noopener noreferrer" target="_blank">Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis (2019), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3562736/" rel="nofollow noopener noreferrer" target="_blank">Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14 (2013), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7033038/" rel="nofollow noopener noreferrer" target="_blank">Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development (2020), PubMed Central</a></li>
<li><a href="https://my.clevelandclinic.org/health/diseases/22724-leaky-gut-syndrome" rel="nofollow noopener noreferrer" target="_blank">My (my.clevelandclinic.org)</a></li>
<li><a href="https://www.health.harvard.edu/diseases-and-conditions/what-is-leaky-gut-syndrome" rel="nofollow noopener noreferrer" target="_blank">Health (health.harvard.edu)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5567597/" rel="nofollow noopener noreferrer" target="_blank">Therapeutic Uses of Triphala in Ayurvedic Medicine (2017), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/22048538/" rel="nofollow noopener noreferrer" target="_blank">A clinical study on the role of ama in relation to Grahani Roga and its management by Kalingadi Ghanavati and Tryushnadi Ghrita (2010), PubMed</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/27047049/" rel="nofollow noopener noreferrer" target="_blank">Evaluation of antidiarrheal activity of ethanolic extract of Holarrhena antidysenterica seeds in rats (2015), PubMed</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/24696573/" rel="nofollow noopener noreferrer" target="_blank">Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome (2013), PubMed</a></li>
</ol>
]]></content:encoded>
					
					<wfw:commentRss>https://www.ayurvedhealing.com/gut-permeability-testing-grahani-lab-markers-classical-diagnosis/feed/</wfw:commentRss>
			<slash:comments>26</slash:comments>
		
		
			</item>
		<item>
		<title>Ayurvedic Herbs and Gut Barrier Integrity: Zonulin, Tight Junctions, and Mucosal Repair</title>
		<link>https://www.ayurvedhealing.com/ayurvedic-herbs-gut-barrier-zonulin-tight-junctions-mucosal/</link>
					<comments>https://www.ayurvedhealing.com/ayurvedic-herbs-gut-barrier-zonulin-tight-junctions-mucosal/#comments</comments>
		
		<dc:creator><![CDATA[Dr. Meera Iyer]]></dc:creator>
		<pubDate>Fri, 31 Jul 2026 12:00:00 +0000</pubDate>
				<category><![CDATA[Research & Science]]></category>
		<category><![CDATA[Grahani Research]]></category>
		<category><![CDATA[Gut Barrier]]></category>
		<category><![CDATA[Intestinal Permeability]]></category>
		<category><![CDATA[leaky gut]]></category>
		<category><![CDATA[Mucosal Repair]]></category>
		<category><![CDATA[Tight Junctions]]></category>
		<category><![CDATA[Zonulin]]></category>
		<guid isPermaLink="false">https://www.ayurvedhealing.com/?p=3410</guid>

					<description><![CDATA[Ayurvedic Herbs and Gut Barrier Integrity: Zonulin, Tight Junctions, and Mucosal Repair Increased intestinal permeability refers to a loss of normal selectivity in the intestinal lining, allowing more luminal material to cross between epithelial cells than would ordinarily pass. In modern physiology, this subject is discussed through the mucus layer, epithelial cells, tight junction proteins, [&#8230;]]]></description>
										<content:encoded><![CDATA[<h1>Ayurvedic Herbs and Gut Barrier Integrity: Zonulin, Tight Junctions, and Mucosal Repair</h1>
<p>Increased intestinal permeability refers to a loss of normal selectivity in the intestinal lining, allowing more luminal material to cross between epithelial cells than would ordinarily pass. In modern physiology, this subject is discussed through the mucus layer, epithelial cells, tight junction proteins, immune surveillance, microbial metabolites, and permeability regulators such as zonulin. In Ayurveda, the closest clinical frame is not a literal ancient description of zonulin, but the classical understanding of <em>grahani</em>, <em>agni</em>, <em>ama</em>, <em>srotas</em>, and the need to restore proper digestion, absorption, retention, and elimination.</p>
<p>Charaka Samhita places <em>grahani</em> in close relationship with <em>agni</em>. When digestive fire is impaired, food is not properly processed, stools become irregular, and systemic symptoms may arise from disordered digestion and assimilation. This makes <em>grahani roga</em> an important Ayurvedic lens for discussing gut barrier weakness, malabsorption, mucus disturbance, diarrhea tendency, and alternating bowel patterns.</p>
<h2>Understanding the Gut Barrier</h2>
<p>The intestinal barrier is not a single wall. It is a layered system in which mucus, epithelial cells, tight junctions, immune factors, and the microbiome work together to keep digestion selective rather than inflammatory. The following table gives an integrative view; the Ayurvedic column is a functional analogy, not a claim of identical anatomy.</p>
<table border="1" cellpadding="8" cellspacing="0" style="width:100%; border-collapse:collapse; margin:20px 0;">
<thead style="background-color:#f5f0e8;">
<tr>
<th style="text-align:left;">Barrier Layer</th>
<th style="text-align:left;">Key Components</th>
<th style="text-align:left;">Modern Function</th>
<th style="text-align:left;">Ayurvedic Functional Parallel</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mucus layer</td>
<td>MUC2 mucin, water, antimicrobial peptides, secretory IgA</td>
<td>Separates microbes and irritants from the epithelial surface</td>
<td><em>Shleshma</em> and protective <em>kapha</em> function</td>
</tr>
<tr>
<td>Epithelial surface</td>
<td>Enterocytes, goblet cells, Paneth cells, enteroendocrine cells</td>
<td>Selective absorption, secretion, immune signalling</td>
<td><em>Grahani</em> as the functional seat of digestion and retention</td>
</tr>
<tr>
<td>Tight junctions</td>
<td>Claudins, occludin, ZO-1, ZO-2 and related proteins</td>
<td>Regulates paracellular passage between epithelial cells</td>
<td><em>Srotas</em> integrity and proper containment of processed nutrients</td>
</tr>
<tr>
<td>Lamina propria</td>
<td>Macrophages, dendritic cells, T cells, B cells, plasma cells</td>
<td>Immune response, tolerance, and inflammatory control</td>
<td><em>Vyadhi kshamatva</em>, tissue defence, and balanced immune response</td>
</tr>
<tr>
<td>Microbial-metabolic layer</td>
<td>Commensal bacteria, short-chain fatty acids, bile acid metabolites</td>
<td>Feeds colonocytes, shapes mucus and immune tone</td>
<td><em>Agni</em>, <em>pachana</em>, and wholesome transformation of food</td>
</tr>
</tbody>
</table>
<p>Zonulin is a human protein involved in reversible regulation of tight junction permeability. Enteric bacteria and gluten exposure in susceptible contexts are among the described triggers of zonulin release. Zonulin and intestinal permeability have been examined in celiac disease, type 1 diabetes, inflammatory bowel disease, and other immune-inflammatory conditions. At the same time, commercial zonulin assays need cautious interpretation because several commonly used tests do not measure a single, uniquely defined zonulin molecule.</p>
<h2>The Ayurvedic Frame: Grahani, Agni, Ama, and Mucosal Protection</h2>
<p>Ayurveda approaches this subject through function: whether food is digested completely, whether stools are formed and retained properly, whether mucus and lubrication are adequate, and whether the channels remain clear. A <em>grahani</em>-oriented plan therefore does not simply “seal” the gut; it first restores <em>agni</em>, reduces <em>ama</em>, supports appropriate <em>grahi</em> action when stools are loose, and nourishes the mucosal surface when there is dryness, burning, depletion, or irritation.</p>
<p>Classical categories useful in this discussion include <em>deepana</em> herbs that kindle digestive capacity, <em>pachana</em> herbs that help process undigested residues, <em>grahi</em> herbs that support stool formation and retention, <em>snigdha</em> and <em>madhura</em> substances that nourish and lubricate tissues, and <em>rasayana</em> dravyas that support resilience over time. These categories allow a more individualized plan than a generic gut-repair supplement list.</p>
<h2>Key Ayurvedic Herbs for Grahani-Type Barrier Support</h2>
<p>The herbs below are included because they have classical relevance to <em>grahani</em>, <em>atisara</em>, digestion, mucosal protection, or immune balance, and because modern pharmacology gives plausible support for their use in gut-barrier-oriented care. They should be selected according to constitution, symptoms, stool pattern, heat or dryness, medication use, and diagnosis.</p>
<h3>1. Kutaja (Holarrhena antidysenterica)</h3>
<p>Kutaja bark is one of the most important Ayurvedic herbs for loose stools, dysentery-type conditions, and <em>grahi</em> support. The Ayurvedic Pharmacopoeia of India identifies Kutaja as the dried stem bark of <em>Holarrhena antidysenterica</em> and lists its actions as <em>dipana</em>, <em>sangrahi</em>, and <em>kaphapittashamaka</em>, with therapeutic use in <em>atisara</em> and <em>pravahika</em>. Its listed properties are <em>tikta</em> and <em>kashaya rasa</em>, <em>laghu</em> and <em>ruksha guna</em>, <em>shita virya</em>, and <em>katu vipaka</em>.</p>
<p>From a gut-barrier perspective, Kutaja is best understood as a stool-stabilizing and anti-diarrhoeal herb rather than as a directly proven zonulin-lowering herb. Its bark contains steroidal alkaloids, including conessine-related constituents, and remains especially relevant when the dominant presentation includes loose stools, mucus, urgency, or chronic <em>grahani</em>-type instability. It is not a routine choice for constipation-dominant patterns, marked dryness, or depletion without professional guidance.</p>
<h3>2. Bilva (Aegle marmelos)</h3>
<p>Bilva fruit pulp is a classical <em>grahi</em> and <em>pachana</em> dravya. The Ayurvedic Pharmacopoeia of India describes Bilva fruit pulp as coming from the unripe or half-ripe fruit of <em>Aegle marmelos</em>, and lists its properties as <em>katu</em>, <em>tikta</em>, and <em>kashaya rasa</em>, <em>laghu</em> and <em>ruksha guna</em>, <em>ushna virya</em>, and <em>katu vipaka</em>. Its listed actions include <em>dipana</em>, <em>grahi</em>, <em>pachana</em>, and <em>vatakaphahara</em>, with use in <em>pravahika</em>, <em>agnimandya</em>, and <em>grahani roga</em>.</p>
<p>Modern work on unripe Bilva fruit supports its traditional role in diarrhoea-oriented care and intestinal secretion control. Its tannins, mucilage, and related phytochemicals make it especially appropriate when the goal is to reduce excessive liquidity and support formed stool. In a barrier-repair plan, Bilva is therefore more suitable for loose, unformed, mucus-associated bowel patterns than for dry constipation.</p>
<h3>3. Shatavari (Asparagus racemosus)</h3>
<p>Shatavari root is used in Ayurveda as a nourishing, strengthening, and mucosal-supportive herb. The Ayurvedic Pharmacopoeia of India identifies Shatavari as <em>Asparagus racemosus</em> root and lists it as <em>madhura</em> and <em>tikta rasa</em>, <em>guru</em> and <em>picchila guna</em>, <em>ushna virya</em>, and <em>madhura vipaka</em>, with <em>brimhana</em>, <em>rasayana</em>, <em>pushtiprada</em>, and <em>balaprada</em> actions.</p>
<p>In gut-barrier language, Shatavari belongs to the mucosal-nourishing side of the protocol. It is more appropriate when there is irritation, burning, tissue depletion, dryness, weakness, or a need for gentle anabolic support. Animal models of gastroduodenal mucosal injury have documented protective effects on mucus-related defensive factors, making Shatavari a useful bridge between the Ayurvedic idea of <em>picchila</em>, nourishing protection and the modern idea of mucosal defence.</p>
<h3>4. Yashtimadhu (Glycyrrhiza glabra)</h3>
<p>Yashtimadhu, or licorice root, is classically sweet, unctuous, cooling, and soothing. Traditional descriptions commonly list it as <em>madhura rasa</em>, <em>guru</em> and <em>snigdha guna</em>, <em>shita virya</em>, and <em>madhura vipaka</em>, with a protective and pitta-pacifying profile. In gut-barrier support, it is most relevant where the mucosa is irritated, dry, inflamed, or burning.</p>
<p>Licorice preparations are associated with increased gastric mucus and prostaglandin-mediated mucosal defence. This makes Yashtimadhu a good example of an Ayurvedic <em>snigdha-madhura</em> herb whose traditional soothing profile aligns with modern mucosal-protective mechanisms. However, whole licorice containing glycyrrhizin can raise blood pressure, lower potassium, and interact with medicines; deglycyrrhizinated preparations and clinician supervision may be preferable for some people.</p>
<h3>5. Guduchi (Tinospora cordifolia)</h3>
<p>Guduchi is a classical <em>rasayana</em> and immune-modulating herb used across digestive, febrile, inflammatory, and metabolic contexts. The Ayurvedic Pharmacopoeia of India identifies Guduchi as the stem of <em>Tinospora cordifolia</em>. In gut-barrier support, its best role is not as a proven direct mucin-gene stimulant, but as a resilience-supporting herb used when inflammation, low vitality, recurrent illness tendency, or disturbed immune tone accompanies digestive weakness.</p>
<p>Guduchi should be used with care in people with autoimmune disease, liver disease, transplant history, or immune-suppressing medication. Liver injury reports linked to <em>Tinospora</em>-containing products make correct identification, quality control, and professional supervision important.</p>
<h3>6. Haridra and Curcumin (Curcuma longa)</h3>
<p>Haridra is traditionally used for <em>kapha</em>, <em>pitta</em>, skin, inflammatory, and metabolic conditions. Curcumin, a major turmeric constituent, has been evaluated in intestinal epithelial and animal models for effects on tight junction organization, inflammatory signalling, and barrier function. Its relevance in this article is as a barrier-modulating anti-inflammatory constituent, not as a stand-alone cure for intestinal permeability.</p>
<p>Curcumin-containing preparations are best considered when gut-barrier weakness is accompanied by inflammatory tendency, metabolic burden, or sluggish <em>kapha-pitta</em> patterns. High-dose curcumin supplements may interact with anticoagulants, antiplatelet drugs, gallbladder disease, and perioperative care, so they should not be used casually in medicinal doses.</p>
<h3>7. Triphala and Polyphenol-Rich Support</h3>
<p>Triphala combines the fruits Haritaki, Bibhitaki, and Amalaki. In classical use it is a bowel-normalizing, digestive, and <em>rasayana</em>-oriented formula rather than a narrow tight-junction drug. Its relevance to gut-barrier care comes from its long digestive use, tannin- and polyphenol-rich profile, and compatibility with maintenance plans when the stool pattern and constitution suit it.</p>
<p>Quercetin is a plant flavonoid that has been evaluated in intestinal epithelial models for effects on claudin, occludin, and ZO protein organization. This offers a useful mechanistic reference for polyphenol-rich botanicals, but it should not be overstated as proof that Triphala acts mainly by delivering a large quercetin dose. Triphala should be used according to bowel pattern: it may suit constipation tendency and sluggish digestion, but can aggravate some loose-stool or depleted patterns if used inappropriately.</p>
<h2>The Mucus Layer: First Line of Barrier Defence</h2>
<p>Tight junctions receive much attention, but the mucus layer is equally important. Goblet cells secrete MUC2 mucin, which forms a protective layer between luminal microbes and the epithelial surface. Secretory IgA also participates in mucosal defence by helping neutralize microbes and toxins and by supporting immune tolerance at the intestinal surface.</p>
<table border="1" cellpadding="8" cellspacing="0" style="width:100%; border-collapse:collapse; margin:20px 0;">
<thead style="background-color:#f5f0e8;">
<tr>
<th style="text-align:left;">Support</th>
<th style="text-align:left;">Barrier Relevance</th>
<th style="text-align:left;">Ayurvedic Interpretation</th>
<th style="text-align:left;">Best Fit</th>
</tr>
</thead>
<tbody>
<tr>
<td>Shatavari</td>
<td>Supports mucosal defence in gastroduodenal models</td>
<td><em>Guru</em>, <em>picchila</em>, <em>brimhana</em>, <em>rasayana</em></td>
<td>Dryness, burning, weakness, depletion</td>
</tr>
<tr>
<td>Yashtimadhu</td>
<td>Associated with mucus and prostaglandin-mediated mucosal protection</td>
<td><em>Madhura</em>, <em>snigdha</em>, <em>shita</em>, pitta-pacifying</td>
<td>Burning, irritation, reflux-like sensitivity, dryness</td>
</tr>
<tr>
<td>Bilva</td>
<td>Supports stool formation and reduces excessive liquidity</td>
<td><em>Grahi</em>, <em>pachana</em>, <em>dipana</em></td>
<td>Loose stool, mucus, weak digestion</td>
</tr>
<tr>
<td>Kutaja</td>
<td>Classical anti-diarrhoeal and <em>sangrahi</em> herb</td>
<td><em>Tikta-kashaya</em>, <em>ruksha</em>, <em>shita</em>, <em>sangrahi</em></td>
<td>Diarrhoea tendency, dysentery-type patterns, <em>grahani</em> instability</td>
</tr>
<tr>
<td>Psyllium / Isabgol</td>
<td>Soluble fibre can improve stool water balance and support microbiota-derived metabolites</td>
<td>Bulk-forming, soothing, stool-regulating when used with adequate water</td>
<td>Constipation or irregular stools when tolerated</td>
</tr>
<tr>
<td>Ghrita used appropriately</td>
<td>Used as a nourishing vehicle and unctuous support in Ayurveda</td>
<td><em>Sneha</em>, <em>anupana</em>, tissue lubrication</td>
<td>Dryness and depletion when digestion can handle fats</td>
</tr>
</tbody>
</table>
<h2>Practitioner-Guided Framework for Gut Barrier Repair</h2>
<p>A safe Ayurvedic plan should be built around the person’s stool pattern, appetite, tongue coating, pain, heat, mucus, bleeding, weight changes, medication use, and diagnosis. The following framework preserves the classical sequence: first restore digestion, then support the mucosa, then stabilize the bowel environment, then maintain.</p>
<h3>Phase 1: Deepana-Pachana and Reducing Ama</h3>
<p>The first phase is for people with heaviness, bloating, coated tongue, poor appetite, foul stools, or a sense that food remains undigested. Food should be warm, cooked, simple, and easy to digest. Ginger, cumin, coriander, fennel, ajwain, or hing may be used in food according to constitution. Stronger formulations such as Chitrakadi Vati should be used only when appropriate because Chitraka is hot, sharp, and not suitable for every pitta-dominant or inflamed presentation.</p>
<ul>
<li>Prefer warm, freshly cooked meals over cold, stale, heavy, or incompatible meals.</li>
<li>Use spices gently; more heat is not better when burning, bleeding, ulcers, or active inflammation is present.</li>
<li>Do not begin heavy mucosal tonics while appetite is very weak and <em>ama</em> signs are strong.</li>
</ul>
<h3>Phase 2: Grahi and Mucosal Support</h3>
<p>Once digestion is clearer, the second phase addresses the dominant pattern. Loose, watery, mucus-associated stools call for <em>grahi</em> herbs such as Bilva or Kutaja under guidance. Burning, dryness, depletion, or irritated mucosa calls for gentler nourishing support such as Shatavari, Yashtimadhu, or ghrita-based preparations when tolerated.</p>
<ul>
<li>Loose stool pattern: Bilva, Kutaja, Kutajarishta-type preparations, or Bilvadi formulations may be considered by a practitioner.</li>
<li>Dry and irritated pattern: Shatavari, Yashtimadhu, ghrita, or other <em>snigdha</em> supports may be selected.</li>
<li>Mixed pattern: formulas should be individualized rather than combining every herb at once.</li>
</ul>
<h3>Phase 3: Microbiota, Fibre, and Stool Rhythm</h3>
<p>After acute instability settles, the plan should support regularity and microbial metabolism. Cooked plant fibres, rice gruels, mung preparations, buttermilk preparations when tolerated, and soluble fibre such as psyllium may help stool form and bowel rhythm. Fermented foods should be introduced cautiously in people with bloating, histamine sensitivity, active diarrhoea, or lactose intolerance.</p>
<ul>
<li>Use soluble fibre gradually and with enough water.</li>
<li>Choose cultured foods only when they suit the person’s digestion.</li>
<li>Maintain meal timing and avoid constant snacking when <em>agni</em> is weak.</li>
</ul>
<h3>Phase 4: Maintenance</h3>
<p>Maintenance is not a permanent high-dose herb plan. It is a steady pattern of suitable food, stable meal timing, adequate sleep, stress regulation, and seasonal adjustment. Triphala, small amounts of ghrita, takra preparations, or light <em>deepana</em> spices may be useful for some people, but each should match the person’s constitution and bowel pattern.</p>
<ul>
<li>Use Triphala only when it supports, rather than loosens or depletes, the person’s bowel pattern.</li>
<li>Use ghee only when fat digestion is comfortable and the broader diet allows it.</li>
<li>Reassess if symptoms recur, worsen, or require continuous herbal suppression.</li>
</ul>
<h2>What Damages Gut Barrier Function</h2>
<p>Barrier repair also requires removing avoidable irritants. Ayurveda expresses this through avoidance of <em>nidana</em>, while modern gastroenterology recognizes several exposures that can disturb mucus, tight junctions, microbial balance, or immune tone.</p>
<ul>
<li><strong>Untreated celiac disease or gluten sensitivity in susceptible people:</strong> Gluten exposure is a known zonulin trigger in celiac disease and related susceptibility contexts.</li>
<li><strong>Enteric infection and dysbiosis:</strong> Certain bacteria can trigger permeability pathways and inflammatory signalling.</li>
<li><strong>Regular NSAID use:</strong> Ibuprofen, aspirin, naproxen, and related drugs can increase small intestinal permeability and injure the intestinal mucosa in some users.</li>
<li><strong>Alcohol:</strong> Alcohol can disrupt tight junctions, alter microbiota, and increase translocation of bacterial products.</li>
<li><strong>Chronic stress:</strong> Stress can affect gut permeability, mast-cell activity, mucus, motility, and secretory IgA.</li>
<li><strong>Unnecessary broad-spectrum antibiotics:</strong> Antibiotics can disturb commensal bacteria that help maintain barrier function through short-chain fatty acids and immune modulation.</li>
<li><strong>Cold, heavy, irregular, or incompatible eating patterns:</strong> In Ayurveda these weaken <em>agni</em>, increase <em>ama</em>, and aggravate <em>grahani</em> instability in susceptible people.</li>
</ul>
<h2>Measuring Gut Barrier and Related Inflammation</h2>
<p>Testing should be chosen by a qualified clinician because digestive symptoms may arise from celiac disease, inflammatory bowel disease, infection, pancreatic or biliary disorders, medication injury, endocrine disease, food intolerance, or functional bowel disorders. Barrier-oriented tests can be useful, but they are not substitutes for diagnosis.</p>
<ul>
<li><strong>Lactulose-mannitol permeability testing:</strong> A noninvasive method used to assess small-intestinal permeability through differential urinary recovery of two sugars.</li>
<li><strong>Zonulin testing:</strong> Sometimes offered as a permeability marker, but interpretation is limited by assay specificity and should not be used alone.</li>
<li><strong>Fecal calprotectin:</strong> A stool marker of intestinal inflammation, especially useful in distinguishing inflammatory bowel disease activity from non-inflammatory patterns.</li>
<li><strong>Secretory IgA:</strong> A mucosal immune marker that may help describe immune tone, but it should be interpreted in clinical context.</li>
<li><strong>LPS-related markers:</strong> Markers related to bacterial product translocation may be used in specialized settings, but they are not routine stand-alone diagnostic tools.</li>
<li><strong>Condition-specific tests:</strong> Celiac serology, stool pathogen testing, colonoscopy, endoscopy, imaging, CBC, CRP, and nutritional markers may be more important when red flags are present.</li>
</ul>
<h2>Red Flags and Safety</h2>
<p>Persistent diarrhoea, blood in stool, black stool, unexplained weight loss, fever, night symptoms, anaemia, severe abdominal pain, repeated vomiting, dehydration, or symptoms in children, pregnancy, older age, or immunocompromised states require medical evaluation. Herbal protocols should not delay diagnosis or replace treatment for celiac disease, inflammatory bowel disease, infection, ulcers, cancer, or autoimmune disease.</p>
<p><em><strong>Medical Disclaimer:</strong> This article is for educational purposes only and does not constitute medical advice. Increased intestinal permeability can be associated with medical conditions that require proper diagnosis and treatment. Consult a qualified Ayurvedic practitioner and healthcare provider before using herbs or formulations, especially if you take medicines, are pregnant or breastfeeding, have hypertension, kidney disease, liver disease, autoimmune disease, inflammatory bowel disease, celiac disease, gallbladder disease, or ongoing gastrointestinal symptoms.</em></p>
<h2>Summary</h2>
<p>The strongest Ayurvedic way to understand gut barrier repair is through <em>grahani</em> and <em>agni</em>: digestion must be clear, stools must be stable, mucus and lubrication must be appropriate, and the channels must remain balanced. Kutaja and Bilva belong to the <em>grahi</em> side of care; Shatavari, Yashtimadhu, and ghrita belong to the mucosal-nourishing side; Guduchi and Triphala may support resilience and long-term digestive regulation when selected properly; and curcumin and quercetin illustrate how plant compounds can influence tight-junction biology in modern models. The best result comes from matching the herb to the person, not from treating “leaky gut” as a single uniform diagnosis.</p>
<h2>References</h2>
<ol>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3458511/" rel="nofollow noopener noreferrer" target="_blank">Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications (2012), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/22109896/" rel="nofollow noopener noreferrer" target="_blank">Leaky gut and autoimmune diseases (2012), PubMed</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/21248165/" rel="nofollow noopener noreferrer" target="_blank">Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer (2011), PubMed</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8355880/" rel="nofollow noopener noreferrer" target="_blank">Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability (2021), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4281373/" rel="nofollow noopener noreferrer" target="_blank">The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system (2014), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3774538/" rel="nofollow noopener noreferrer" target="_blank">Secretory IgA&#8217;s complex roles in immunity and mucosal homeostasis in the gut (2011), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9427709/" rel="nofollow noopener noreferrer" target="_blank">Tight junction proteins occludin and ZO-1 as regulators of epithelial proliferation and survival (2022), PubMed Central</a></li>
<li><a href="https://www.irjournal.org/journal/view.php?doi=10.5217/ir.2015.13.1.11" rel="nofollow noopener noreferrer" target="_blank">Irjournal (irjournal.org)</a></li>
<li><a href="https://www.carakasamhitaonline.com/index.php/Grahani_Chikitsa" rel="nofollow noopener noreferrer" target="_blank">Charaka Samhita — Grahani Chikitsa</a></li>
<li><a href="https://www.ayurveda.hu/api/API-Vol-1.pdf" rel="nofollow noopener noreferrer" target="_blank">Ayurvedic Pharmacopoeia of India</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5628520/" rel="nofollow noopener noreferrer" target="_blank">Review of Holarrhena antidysenterica (L.) Wall. ex A. DC.: Pharmacognostic, Pharmacological, and Toxicological Perspective (2017), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/19930633/" rel="nofollow noopener noreferrer" target="_blank">Studies on the antidiarrhoeal activity of Aegle marmelos unripe fruit: validating its traditional usage (2009), PubMed</a></li>
<li><a href="https://europepmc.org/article/med/16281828" rel="nofollow noopener noreferrer" target="_blank">Europepmc (europepmc.org)</a></li>
<li><a href="https://www.ayurveda.hu/api/API-Vol-4.pdf" rel="nofollow noopener noreferrer" target="_blank">Ayurvedic Pharmacopoeia of India</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/12686434/" rel="nofollow noopener noreferrer" target="_blank">Gastroduodenal ulcer protective activity of Asparagus racemosus: an experimental, biochemical and histological study (2003), PubMed</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/17135157/" rel="nofollow noopener noreferrer" target="_blank">Antisecretory and antiulcer activity of Asparagus racemosus Willd. against indomethacin plus phyloric ligation-induced gastric ulcer in rats (2006), PubMed</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/15777415/" rel="nofollow noopener noreferrer" target="_blank">Development of an inner urban homeless mental health service (2005), PubMed</a></li>
<li><a href="https://hamc.org.in/himalayan/document/therapeutic-and-medicinal-uses-of-yashtimadhu-a-review.pdf" rel="nofollow noopener noreferrer" target="_blank">Hindu American Medical College</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8220166/" rel="nofollow noopener noreferrer" target="_blank">Phytochemistry, pharmacological activity, and potential health benefits of Gly cyrrhiza glabra (2021), PubMed Central</a></li>
<li><a href="https://www.nccih.nih.gov/health/licorice-root" rel="nofollow noopener noreferrer" target="_blank">NCCIH</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/2785475/" rel="nofollow noopener noreferrer" target="_blank">Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus (1989), PubMed</a></li>
<li><a href="https://miracledrinksclinic.com/Liquids/Immun_Care/Guduchi_Stem.pdf" rel="nofollow noopener noreferrer" target="_blank">Miracledrinksclinic (miracledrinksclinic.com)</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/18167043/" rel="nofollow noopener noreferrer" target="_blank">Validation of therapeutic claims of Tinospora cordifolia: a review (2008), PubMed</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3644751/" rel="nofollow noopener noreferrer" target="_blank">Tinospora cordifolia: One plant, many roles (2012), PubMed Central</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/books/NBK608429/" rel="nofollow noopener noreferrer" target="_blank">NCBI</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/22231434/" rel="nofollow noopener noreferrer" target="_blank">Genetic polymorphisms of ALDH2 and ADH2 are not associated with risk of hepatocellular carcinoma among East Asians (2012), PubMed</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5407015/" rel="nofollow noopener noreferrer" target="_blank">Curcumin improves intestinal barrier function: modulation of intracellular signaling, and organization of tight junctions (2017), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9197639/" rel="nofollow noopener noreferrer" target="_blank">Curcumin Improved Intestinal Epithelial Barrier Integrity by Up-Regulating ZO-1/Occludin/Claudin-1 in Septic Rats (2022), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/28267166/" rel="nofollow noopener noreferrer" target="_blank">Fingerprinting seamless single-walled carbon nanotube junctions via the migration of encapsulated N(2) molecules from bottom to top: are arrays of VA-SWNTs continuous? (2017), PubMed</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/19297429/" rel="nofollow noopener noreferrer" target="_blank">Quercetin enhances intestinal barrier function through the assembly of zonula [corrected] occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells (2009), PubMed</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/19210596/" rel="nofollow noopener noreferrer" target="_blank">Different transmission strategies of a parasite in male and female hosts (2009), PubMed</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6052535/" rel="nofollow noopener noreferrer" target="_blank">Triphala: current applications and new perspectives on the treatment of functional gastrointestinal disorders (2018), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5567597/" rel="nofollow noopener noreferrer" target="_blank">Therapeutic Uses of Triphala in Ayurvedic Medicine (2017), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6421268/" rel="nofollow noopener noreferrer" target="_blank">Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases (2019), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6358997/" rel="nofollow noopener noreferrer" target="_blank">The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls (2019), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/14988448/" rel="nofollow noopener noreferrer" target="_blank">A high dairy protein, high-calcium diet minimizes bone turnover in overweight adults during weight loss (2004), PubMed</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1727292/" rel="nofollow noopener noreferrer" target="_blank">Intestinal permeability and inflammation in patients on NSAIDs (1998), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6013262/" rel="nofollow noopener noreferrer" target="_blank">Nonsteroidal Anti-Inflammatory Drug-Induced Leaky Gut Modeled Using Polarized Monolayers of Primary Human Intestinal Epithelial Cells (2018), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9372561/" rel="nofollow noopener noreferrer" target="_blank">Gut microbiota dysbiosis: The potential mechanisms by which alcohol disrupts gut and brain functions (2022), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10569989/" rel="nofollow noopener noreferrer" target="_blank">Psychosocial stress-induced intestinal permeability in healthy humans: What is the evidence? (2023), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3845795/" rel="nofollow noopener noreferrer" target="_blank">Stress modulates intestinal secretory immunoglobulin A (2013), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6705842/" rel="nofollow noopener noreferrer" target="_blank">The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity (2019), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7033038/" rel="nofollow noopener noreferrer" target="_blank">Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development (2020), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6687120/" rel="nofollow noopener noreferrer" target="_blank">Measurement of intestinal permeability using lactulose and mannitol with conventional five hours and shortened two hours urine collection by two different methods: HPAE-PAD and LC-MSMS (2019), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6370282/" rel="nofollow noopener noreferrer" target="_blank">Faecal Calprotectin (2018), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6970489/" rel="nofollow noopener noreferrer" target="_blank">The Effects of Secretory IgA in the Mucosal Immune System (2020), PubMed Central</a></li>
<li><a href="https://ayush.delhi.gov.in/faqs/ayurveda" rel="nofollow noopener noreferrer" target="_blank">Ayush (ayush.delhi.gov.in)</a></li>
</ol>
]]></content:encoded>
					
					<wfw:commentRss>https://www.ayurvedhealing.com/ayurvedic-herbs-gut-barrier-zonulin-tight-junctions-mucosal/feed/</wfw:commentRss>
			<slash:comments>27</slash:comments>
		
		
			</item>
	</channel>
</rss>
